Amcinonide: Indication, Dosage, Side Effect, Precaution

This information is not country-specific. Please refer to the Malaysia prescribing information.

Generic Medicine Info

Indications and Dosage

Topical/Cutaneous
Corticosteroid-responsive dermatoses

Adult: As 0.1% cream/oint/lotion: Apply sparingly in a thin film to affected area bid or tid, depending on the severity of the condition.

Special Precautions

Childn. Pregnancy and lactation.

Adverse Reactions

Burning, itching, soreness, stinging, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin maceration and atrophy, striae, miliaria; HPA axis and growth suppression, Cushing’s syndrome, hyperglycaemia, glucosuria.

Pregnancy Category (US FDA)

Topical: C

Patient Counseling Information

Do not use on the face, groin, or axilla. Avoid use of occlusive dressings in the presence of infected or weeping lesions.

Monitoring Parameters

Perform urinary free cortisol and ACTH stimulation tests to monitor for hypothalamic-pituitary-adrenal (HPA) axis suppression if drug is applied to a large surface area or under an occlusive dressing.

Lab Interference

May diminish the therapeutic effect of aldesleukin, corticorelin and hyaluronidase. May enhance the hyperglycaemic effect of ceritinib. May increase the adverse/toxic effect of deferasirox.

Action

Description:
Mechanism of Action: Amcinonide, a synthetic fluorinated glucocorticoid, has anti-inflammatory, antipruritic, and vasoconstrictive actions. It induces phospholipase A₂ inhibitory proteins (lipocortins) and sequentially inhibits the release of arachidonic acid, thereby depressing the formation, release, and activity of endogenous chemical mediators of inflammation.
Pharmacokinetics:
Absorption: Adequately absorbed through intact skin and increases w/ inflammation/occlusion.
Metabolism: Metabolised in the liver.
Excretion: Via urine and faeces.

Chemical Structure

Storage

Store between 15-30°C. Do not freeze.

MIMS Class

Topical Corticosteroids

ATC Classification

D07AC11 - amcinonide ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.

References

Amcinonide Cream and Ointment (Taro Pharmaceuticals U.S.A., Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/09/2016.

Amcinonide Lotion (Fougera Pharmaceuticals Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/09/2016.

Anon. Amcinonide (Topical). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/09/2016.

Buckingham R (ed). Amcinonide. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/09/2016.

McEvoy GK, Snow EK, Miller J et al (eds). Amcinonide (Topical). AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 05/09/2016.

Disclaimer: This information is independently developed by MIMS based on Amcinonide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com